HCA Healthcare, Inc. (NYSE:HCA) Major Shareholder Of America Corp /De/ Bank Acquires 670 Shares

HCA Healthcare, Inc. (NYSE:HCA) major shareholder Of America Corp /De/ Bank acquired 670 shares of the business’s stock in a transaction that occurred on Tuesday, July 26th. The shares were purchased at an average cost of $27.97 per share, for a total transaction of $18,739.90. The acquisition was disclosed in a document filed with the SEC, which is accessible through the SEC website. Major shareholders that own 10% or more of a company’s shares are required to disclose their transactions with the SEC.

HCA Healthcare Price Performance

Shares of HCA opened at $342.25 on Friday. The stock has a market cap of $84.26 billion, a P/E ratio of 15.58, a P/E/G ratio of 1.10 and a beta of 1.68. The business’s fifty day moving average is $324.53 and its 200 day moving average is $341.56. The company has a quick ratio of 0.97, a current ratio of 1.08 and a debt-to-equity ratio of 69.07. HCA Healthcare, Inc. has a 12-month low of $289.98 and a 12-month high of $417.14.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Friday, January 24th. The company reported $6.22 earnings per share for the quarter, topping analysts’ consensus estimates of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same period last year, the firm posted $5.90 EPS. Sell-side analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, March 31st. Stockholders of record on Monday, March 17th will be paid a $0.72 dividend. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.66. The ex-dividend date of this dividend is Monday, March 17th. This represents a $2.88 annualized dividend and a dividend yield of 0.84%. HCA Healthcare’s dividend payout ratio is presently 13.11%.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Congress Wealth Management LLC DE increased its position in shares of HCA Healthcare by 3.4% during the fourth quarter. Congress Wealth Management LLC DE now owns 1,039 shares of the company’s stock valued at $312,000 after acquiring an additional 34 shares during the last quarter. Evergreen Private Wealth LLC increased its position in shares of HCA Healthcare by 0.3% during the 4th quarter. Evergreen Private Wealth LLC now owns 12,787 shares of the company’s stock valued at $3,838,000 after purchasing an additional 35 shares during the last quarter. Mediolanum International Funds Ltd grew its position in HCA Healthcare by 0.3% during the fourth quarter. Mediolanum International Funds Ltd now owns 10,592 shares of the company’s stock valued at $3,153,000 after buying an additional 36 shares during the period. Prairie Wealth Advisors Inc. raised its position in HCA Healthcare by 6.1% in the fourth quarter. Prairie Wealth Advisors Inc. now owns 700 shares of the company’s stock worth $210,000 after acquiring an additional 40 shares during the period. Finally, Whittier Trust Co. increased its stake in shares of HCA Healthcare by 3.6% during the 4th quarter. Whittier Trust Co. now owns 1,195 shares of the company’s stock worth $359,000 after purchasing an additional 41 shares during the last quarter. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

HCA has been the subject of a number of research reports. KeyCorp dropped their price objective on shares of HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating for the company in a report on Tuesday, January 7th. Royal Bank of Canada decreased their price objective on HCA Healthcare from $405.00 to $384.00 and set an “outperform” rating for the company in a report on Monday, January 27th. Barclays decreased their price target on HCA Healthcare from $392.00 to $366.00 and set an “overweight” rating for the company in a research note on Monday, January 27th. Bank of America reduced their target price on HCA Healthcare from $380.00 to $370.00 and set a “buy” rating on the stock in a report on Monday, January 27th. Finally, Truist Financial reduced their price objective on shares of HCA Healthcare from $430.00 to $390.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have assigned a buy rating and two have issued a strong buy rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $385.67.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.